Persistent Asset Partners LTD Gossamer Bio, Inc. Transaction History
Persistent Asset Partners LTD
- $119 Billion
- Q1 2025
A detailed history of Persistent Asset Partners LTD transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 61,984 shares of GOSS stock, worth $77,480. This represents 0.06% of its overall portfolio holdings.
Number of Shares
61,984
Previous 778
7867.1%
Holding current value
$77,480
Previous $24.7 Million
176.6%
% of portfolio
0.06%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding GOSS
# of Institutions
116Shares Held
168MCall Options Held
1.42MPut Options Held
92.6K-
Octagon Capital Advisors LP New York, NY18.4MShares$22.9 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$22.6 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$12.6 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$11 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$10.1 Million4.56% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $117M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...